A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer

NCT03042702 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Kevetrin
DRUG: Kevetrin

Sponsor

Innovation Pharmaceuticals, Inc.